Dynamic Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Dynamic Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,967	Closed	-$244K	–	181
2018 Q2	$244K	Sell	1,967 -33	-2%	-$3.86K	0.39%	84
2018 Q1	$223K	Sell	2,000 -5,539	-73%	-$662K	0.55%	71
2017 Q4	$902K	Buy	7,539 +4,612	+158%	+$562K	0.31%	85
2017 Q3	$411K	Buy	+2,927	New	+$398K	0.12%	203
2017 Q2	–	Sell	-4,769	Closed	-$578K	–	333
2017 Q1	$578K	Buy	+4,769	New	+$615K	0.09%	211
2016 Q2	–	Sell	-3,612	Closed	-$503K	–	507
2016 Q1	$503K	Buy	+3,612	New	+$530K	0.19%	174
2015 Q2	–	Sell	-2,700	Closed	-$468K	–	371
2015 Q1	$468K	Buy	+2,700	New	+$489K	0.17%	143
2014 Q3	–	Sell	-4,107	Closed	-$642K	–	480
2014 Q2	$642K	Sell	4,107 -2,877	-41%	-$454K	0.18%	198
2014 Q1	$1.06M	Buy	+6,984	New	+$1.11M	0.34%	81

Other funds holding ALXN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dynamic Capital Management's ALXN Position: Q3 2018 in Review

Dynamic Capital Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2018, closing a stake of 1,967 shares — an estimated $244K sold.

Dynamic Capital Management first reported a position in ALXN in Q1 2014 and held it in 9 quarters. The position peaked at $1.06M in Q1 2014. 585 funds tracked by Wall St. Rank hold ALXN as of Q3 2018.

Dynamic Capital Management reported no remaining Alexion Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Dynamic Capital Management sold 1,967 Alexion Pharmaceuticals shares in Q3 2018, an estimated $244K.
Dynamic Capital Management first reported a position in Alexion Pharmaceuticals in Q1 2014 and held it in 9 quarters.
Dynamic Capital Management's Alexion Pharmaceuticals position peaked at $1.06M in Q1 2014.
585 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2018.

Based on Dynamic Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.